Lack of relationship between CO2 reactivity and serotonin transporter gene regulatory region polymorphism in panic disorder

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 129 B, Issue 1, 2004, Pages 41-43

  Perna, Giampaolo ^a   Di Bella, Daniela ^a   Favaron, Elisa ^a   Cucchi, Michele ^a   Liperi, Laura ^a   Bellodi, Laura ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

5 HTTLPR; Carbon dioxide; Panic disorder; Panic provocation; Polymorphism; Serotonin

Indexed keywords

CARBON DIOXIDE; SEROTONIN TRANSPORTER; CARRIER PROTEIN; DNA; MEMBRANE PROTEIN; NERVE PROTEIN; SLC6A4 PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANIC; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROVOCATION TEST; SEROTONINERGIC SYSTEM; VISUAL ANALOG SCALE; ALLELE; BREATHING DISORDER; CHEMICALLY INDUCED DISORDER; GENE FREQUENCY; GENETICS; INHALATIONAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; ITALY; MIDDLE AGED; REGULATORY SEQUENCE;

ADMINISTRATION, INHALATION; ADULT; ALLELES; CARBON DIOXIDE; DNA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; ITALY; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; PANIC DISORDER; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); REGULATORY SEQUENCES, NUCLEIC ACID; RESPIRATION DISORDERS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 3342950089     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30035     Document Type: Article

References (26)

1. Argyle N, Deltito J, Allerup P, Maier W, Albus M, Nutzinger D, Rasmussen S, Ayuso JL, Bech P. 1991. The panic-associated symptom scale: Measuring the severity of panic disorder. Acta Psychiatr Scand 83(1): 20-26.
2. 2 challenge in panic disorder: Optimization by receiver operating characteristic (ROC) analysis. J Psychiatr Res 29(2):111-119.
3. 2-induced panic attacks: A twin study. Am J Psychiatry 155(9):1184-1188.
4. 2 hyperreactivity and clinical symptomatology in patients with panic disorder after 1 week of treatment with citalopram: An open study. J Clin Psychopharmacol 21(3):262-267.
5. Coryell W. 1997. Hypersensitivity to carbon dioxide as a disease-specific trait marker. Biol Psychiatry 41(3):259-263.
6. Deckert J, Catalano M, Heils A, Di Bella D, Friess F, Politi E, Franke P, Nothen MM, Maier W, Bellodi L, et al. 1997. Functional promoter polymorphism of the human serotonin transporter: Lack of association with panic disorder. Psychiatr Genet 7(1):45-47.
7. Gorman JM, Papp LA, Martinez J, Goetz RR, Hollander E, Liebowitz MR, Jordan F. 1990. High-dose carbon dioxide challenge test in anxiety disorder patients. Biol Psychiatry 28(9):743-757.
8. 2 vulnerability in panic disorder. Psychiatry Res 20(2):87-95.
9. Hamilton SP, Heiman GA, Haghighi F, Mick S, Klein DF, Hodge SE, Weissman MM, Fyer AJ, Knowles JA. 1999. Lack of genetic linkage or association between a functional serotonin transporter polymorphism and panic disorder. Psychiatr Genet 9(1):1-6.
10. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP. 1996. Allelic variation of human serotonin transporter gene expression. J Neurochem 66(6):2621-2624.
11. Klaassen T, Klumperbeek J, Deutz NE, van Praag HM, Griez E. 1998. Effects of tryptophan depletion on anxiety and on panic provoked by carbon dioxide challenge. Psychiatry Res 77(3):167-174.
12. Klein DF. 1998. Panic and phobic anxiety: Phenotypes, endophenotypes, and genotypes. Am J Psychiatry 155(9):1147-1149.
13. Lahiri DK, Nurnberger JI Jr. 1991. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19(19):5444.
14. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL, 1996. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274(5292):1527-1531.
15. Marks IM, Mathews AM. 1979. Brief standard self-rating for phobic patients. Behav Res Ther 17:263-267.
16. 2-induced anxiety in patients with panic disorder and normal volunteers. Br J Psychiatry 176:182-188.
17. 2 reactivity in panic patients and healthy controls. European Psychiatry 9:236-240.
18. Perna G, Battaglia M, Garberi A, Arancio C, Bertani A, Bellodi L. 1994b. Carbon dioxide/oxygen challenge test in panic disorder. Psychiatry Res 52(2):159-171.
19. 2 in healthy first-degree relatives of patients with panic disorder. Am J Psychiatry 152(4):623-625.
20. 2 in patients with panic disorder. Am J Psychiatry 153(8):1060-1064.
21. 2 hyperreactivity and short-term treatment outcome. J Clin Psychopharmacol 22(3):300-308.
22. Pols H, Zandbergen J, de Loof C, Griez E. 1991. Attenuation of carbon dioxide-induced panic after clonazepam treatment. Acta Psychiatr Scand 84(6):585-586.
23. Schmidt NB, Storey J, Greenberg BD, Santiago HT, Li Q, Murphy DL. 2000. Evaluating gene χ psychological risk factor effects in the pathogenesis of anxiety: A new model approach. J Abnorm Psychol 109(2): 308-320.
24. 2 challenge in healthy volunteers. Prog Neuropsychopharmacol Biol Psychiatry 24(3):409-418.
25. Sheehan DV, Lecrubier Y, Janavs J, Knapp E, Weiler E, Bonora P, Sheedan M, Amorim P, Baker R, Sheehan KH, et al. 1994. Mini International Neuropsychiatric Interview. Paris/Tampa: MINI.
26. 2 challenge in healthy first-degree relatives of patients with panic disorder. Biol Psychiatry 47(9):830-835.